14 terminated. 14 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Terminated 14 |
| Phase 2 | 1 | Terminated 1 |
Follow Disease: new trials by email Literature Review of Disease trials Research Report on Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE XEN496 - Epilepsy, Epilepsy in Children | Phase 3 | Terminated | Xenon Pharmaceuticals Inc. | 8 | 2021-08-17 | 2025-02-14 |
| Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: Montelukast, placebo - Covid19, SARS (Disease) | Phase 3 | Terminated | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 86 | 2021-08-11 | 2024-07-03 |
| XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy XEN496, Placebo - Epilepsy, Epilepsy in Children | Phase 3 | Terminated | Xenon Pharmaceuticals Inc. | 8 | 2021-03-29 | 2024-08-23 |
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. Synergo® RITE + MMC - Bladder Cancer, Bladder Neoplasm | Phase 3 | Terminated | Medical Enterprises Ltd. | 5 | 2019-04-04 | 2020-04-15 |
| Mometasone vs Budesonide in CRS With Polyposis Budesonide 0.5 MG/ML, Mometasone nasal spray - Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis | Phase 3 | Terminated | Université de Sherbrooke | 36 | 2017-05-01 | 2022-09-21 |
| Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease Adrabetadex - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Terminated | Mandos LLC | 66 | 2015-12-23 | 2023-08-29 |
| Rivaroxaban in Thrombotic Antiphospholipid Syndrome Experimental: Rivaroxaban - Antiphospholipid Syndrome | Phase 3 | Terminated | University of Padova | 121 | 2014-12-01 | 2018-01-30 |
| Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia Cocaine HCl 4% Topical Solution, Cocaine HCl 10% Topical Solution, Placebo Topical Solution - Diagnostic, Procedures and Surgeries on or Through Accessible Mucous Membranes | Phase 3 | Terminated | Lannett Company, Inc. | 159 | 2014-03-01 | 2017-05-12 |
| GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma GA101, Rituximab, Doxorubicin - Diffuse Large B Cell Lymphoma CD20 Positive | Phase 3 | Terminated | The Lymphoma Academic Research Organisation | 671 | 2012-09-01 | 2018-03-07 |
| Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) Tegeline® - Drug Hypersensitivity | Phase 3 | Terminated | University Hospital, Rouen | 6 | 2008-01-01 | 2015-03-24 |
| A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery Dexmedetomidine, Placebo - Delirium | Phase 3 | Terminated | Hospira, now a wholly owned subsidiary of Pfizer | 52 | 2007-04-01 | 2015-07-24 |
| Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. Octreotide, 30 mg i.m. LAR formulation - Proliferative Diabetic Retinopathy | Phase 3 | Terminated | Novartis | 17 | 2003-12-01 | 2008-08-12 |
| The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography Spiral Computed Tomography - Lung Cancer | Phase 3 | Terminated | Istituto Clinico Humanitas | 2400 | 2001-06-01 | 2007-01-11 |
| Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) Two diagnostic management strategies - Suspected Pulmonary Embolism, Deep Venous Thrombosis | Phase 3 | Terminated | Hamilton Health Sciences Corporation | 1126 | 1998-08-01 | 2006-05-03 |
Nervous System Diseases (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Epilepsy (2) · Epileptic Syndromes (2) · Seizures (2) · Syndrome (2) · Thrombosis (2) · Antiphospholipid Syndrome (1) · COVID-19 (1) · Cognitive Dysfunction (1) · Deglutition Disorders (1) · Delirium (1) · Drug Hypersensitivity (1)
Pathologic Processes (14) · Pathological Conditions, Signs and Symptoms (14) · Respiratory Tract Diseases (4) · Signs and Symptoms (4) · Immune System Diseases (3) · Lung Diseases (3) · Neoplasms (3) · Neurologic Manifestations (3) · Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Hemic and Lymphatic Diseases (2) · Lymphatic Diseases (2) · Mental Disorders (2) · Neoplasms by Site (2)
ezogabine (2) · 2-Hydroxypropyl-beta-cyclodextrin (1) · Bleomycin (1) · Budesonide (1) · Cocaine (1) · Cyclodextrins (1) · Cyclophosphamide (1) · Dexmedetomidine (1) · Doxorubicin (1) · Mitomycin (1) · Octreotide (1) · Prednisone (1) · Rituximab (1) · Rivaroxaban (1) · Solutions (1)
Xenon Pharmaceuticals Inc. (2) · Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1) · Hamilton Health Sciences Corporation (1) · Hospira, now a wholly owned subsidiary of Pfizer (1) · Istituto Clinico Humanitas (1) · Lannett Company, Inc. (1) · Mandos LLC (1) · Medical Enterprises Ltd. (1) · Novartis (1) · The Lymphoma Academic Research Organisation (1) · University Hospital, Rouen (1) · University of Padova (1) · Université de Sherbrooke (1)
United States (6) · Australia (3) · Belgium (3) · France (3) · Italy (3) · Canada (2) · Spain (2) · Switzerland (2) · Germany (1) · New Zealand (1) · Singapore (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Agnes Y Lee, MD (1) · Alexander G Turpie, MB (1) · Betlem Salvador Gonzalez, PhD (1) · Clive Kearon, MD, PhD (1) · Francisco Mera Cordero, MD (1) · Gianni Ravasi, MD (1) · James Douketis, MD (1) · Jeffrey I Weitz, MD (1) · Jeffrey S Ginsberg, MD (1) · Jesus Almeda Ortega, PhD (1) · Mark A Crowther, MD (1) · Michael A O'Donnell, MD (1) · Michael Gent, DSc (1)
PMID 17936405, PMID 30002145, PMID 33097974, PMID 33211799, PMID 34572728, PMID 34991703, PMID 37422199, PMID 37734837, PMID 40030008, PMID 40934736
2015 (1)